GB202105044D0 - Fusion protein - Google Patents
Fusion proteinInfo
- Publication number
- GB202105044D0 GB202105044D0 GBGB2105044.8A GB202105044A GB202105044D0 GB 202105044 D0 GB202105044 D0 GB 202105044D0 GB 202105044 A GB202105044 A GB 202105044A GB 202105044 D0 GB202105044 D0 GB 202105044D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- fusion protein
- fusion
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/165—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2105044.8A GB2606693A (en) | 2021-04-08 | 2021-04-08 | Fusion protein |
PCT/US2022/023864 WO2022216949A1 (en) | 2021-04-08 | 2022-04-07 | Fusion protein for antigen presentation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2105044.8A GB2606693A (en) | 2021-04-08 | 2021-04-08 | Fusion protein |
Publications (2)
Publication Number | Publication Date |
---|---|
GB202105044D0 true GB202105044D0 (en) | 2021-05-26 |
GB2606693A GB2606693A (en) | 2022-11-23 |
Family
ID=75949647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2105044.8A Pending GB2606693A (en) | 2021-04-08 | 2021-04-08 | Fusion protein |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB2606693A (en) |
WO (1) | WO2022216949A1 (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU725474B2 (en) | 1996-08-16 | 2000-10-12 | Medical Research Council | Self-replicating episomal expression vectors conferring tissue-specific gene expression |
EP1773388A4 (en) * | 2004-06-02 | 2008-08-20 | New York Blood Ct Inc | Sars vaccines and methods to produce highly potent antibodies |
WO2017175253A1 (en) * | 2016-04-04 | 2017-10-12 | 国立研究開発法人医薬基盤・健康・栄養研究所 | Exosome-targeted dna vaccine |
US20220184225A1 (en) * | 2019-04-23 | 2022-06-16 | Case Western Reserve University | Fusogenic particles and related methods for delivering therapeutic agents to cells |
WO2021163222A1 (en) * | 2020-02-11 | 2021-08-19 | Cytonus Therapeutics, Inc. | Rapid vaccine platform |
EP4118211A4 (en) * | 2020-03-13 | 2024-05-29 | The Johns Hopkins University | Selectable marker proteins, expression vectors, for the production of virus-like particles for therapeutic and prophylactic applications |
CN112226413B (en) * | 2020-10-14 | 2022-04-15 | 苏州大学 | Targeting exosome based on SARS-CoV-2S protein RBD region and preparation method thereof |
-
2021
- 2021-04-08 GB GB2105044.8A patent/GB2606693A/en active Pending
-
2022
- 2022-04-07 WO PCT/US2022/023864 patent/WO2022216949A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
GB2606693A (en) | 2022-11-23 |
WO2022216949A1 (en) | 2022-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3880814A4 (en) | Fusion protein | |
SG11202011743SA (en) | Fusion proteins comprising progranulin | |
EP3757218A4 (en) | Fusion protein | |
IL290675A (en) | Therapeutic fusion proteins | |
SG11202101904UA (en) | Spd-1 variant - fc fusion proteins | |
ZA202102533B (en) | Fusion protein | |
ZA202003845B (en) | Fusion proteins | |
SG11202110400QA (en) | Fusion protein and use thereof | |
EP4190803A4 (en) | SIRPa-FC FUSION PROTEIN | |
GB2620875B (en) | A fusion protein comprising IL13 | |
SG11202000775SA (en) | Fusion tags for recombinant protein expression | |
GB202005879D0 (en) | Heterodimeric proteins | |
EP3740501A4 (en) | Fusion protein extensions | |
IL312755A (en) | Sirp1a - and cd40l-based chimeric proteins | |
EP3647426A4 (en) | Fusion protein | |
EP3649159C0 (en) | Fusion protein | |
IL308240A (en) | Fusion polypeptides | |
GB202113559D0 (en) | Fusion polypeptide | |
EP4100444A4 (en) | Mucin-binding fusion proteins | |
GB202105044D0 (en) | Fusion protein | |
GB202307936D0 (en) | Fusion protein | |
GB202307932D0 (en) | Fusion protein | |
GB202218084D0 (en) | Fusion proteins | |
GB201712792D0 (en) | Fusion protein | |
EP4165066A4 (en) | Fusion polypeptide |